Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Anti-tumour immunity

TRIPping anti-tumour immunity through lactylation

KRAS mutations in colorectal cancers shape an immunosuppressive tumour microenvironment. In this issue of Nature Metabolism, Yang et al. report that TRIP6 phosphorylation-induced glycolysis in KRAS-mutant colorectal cancer impedes CD8+ T cell function by the intriguing extracellular lactylation of CD44.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Extracellular lactylation of CD44 mediates the metabolic crosstalk between KRAS‑mutant CRC cells and CD8⁺ T cells.

References

  1. Yaeger, R. et al. Cancer Cell 33, 125–136 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Biller, L. H. & Schrag, D. JAMA 325, 669–685 (2021).

    Article  CAS  PubMed  Google Scholar 

  3. Asimgil, H. et al. JCI Insight 7, e153688 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Liu, W. et al. Nature 616, 790–797 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ren, H., Tang, Y. & Zhang, D. Nat. Metab. 7, 647–664 (2025).

    Article  CAS  PubMed  Google Scholar 

  6. Ju, J. et al. J. Clin. Invest. 134, e174587 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zong, Z. et al. Cell 187, 2375–2392 (2024).

    Article  CAS  PubMed  Google Scholar 

  8. Zhang, C. et al. Cell Death Differ. 32, 2225–2238 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chen, J. et al. Signal Transduct. Target. Ther. 10, 38 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yang, Y. et al. Nat. Metab. https://doi.org/10.1038/s42255-026-01482-3 (2026).

    Article  PubMed  Google Scholar 

  11. Cox, A. D. & Der, C. J. Genes Dev. 39, 132–162 (2025).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Bollyky, P. L. et al. J. Immunol. 183, 2232–2241 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Apostolova, P. & Pearce, E. L. Trends Immunol. 43, 969–977 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ding, R. et al. Immunity 57, 528–540 (2024).

    Article  CAS  PubMed  Google Scholar 

  15. Liu, Y. et al. Sci. Transl. Med. 16, eadk7399 (2024).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xuemei Tong.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, N., Tong, X. TRIPping anti-tumour immunity through lactylation. Nat Metab (2026). https://doi.org/10.1038/s42255-026-01486-z

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s42255-026-01486-z

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer